Skip to main content

Neomycin Polymyxin B Sulfates and Dexamethasone

NDC 50090-0570 · A-S Medication Solutions

Generic nameNeomycin sulfate, Polymyxin B Sulfate and Dexamethasone
Dosage formSUSPENSION/ DROPS
RouteOPHTHALMIC
Active ingredient(s)NEOMYCIN SULFATE, POLYMYXIN B SULFATE, DEXAMETHASONE
Strength1; 3.5; 10000 mg/mL; mg/mL; [USP'U]/mL
Pharmacologic classAminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
Marketing categoryANDA

Packages

50090-0570-0 — 1 BOTTLE, DROPPER in 1 CARTON (50090-0570-0) / 5 mL in 1 BOTTLE, DROPPER

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

49035-847 — Neomycin sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride, 49314-0006 — Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate, 49348-274 — Bacitracin zinc and Polymyxin B sulfate, 49348-600 — polymyxin B sulfate, bacitracin zinc, neomycin sulfate, and pramoxine hydrochloride, 49687-0013 — BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, 50066-202 — Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride, 50090-0234 — Polymyxin B Sulfate, Bacitracin Zinc and Neomycin Sulfate, 50090-0247 — neomycin sulfate, polymyxin b sulfate and gramicidin, 50090-0431 — Neomycin sulfate, Polymyxin B Sulfate and Hydrocortisone, 50090-0433 — Neomycin Sulfate, Polymyxin B Sulfate, Hydrocortisone, 50090-1135 — Tobramycin and Dexamethasone, 50090-1136 — Tobramycin and Dexamethasone, 50090-1859 — bacitracin zinc, neomycin, polymyxin B, 50090-1914 — Tobramycin and Dexamethasone, 50090-2365 — neomycin sulfate, polymyxin b sulfate and hydrocortisone, 50090-2925 — Polymyxin B Sulfate and Trimethoprim, 50090-3274 — Bacitracin Zinc and Polymyxin B Sulfate, 50090-4435 — Neomycin and Polymyxin B Sulfates and Dexamethasone, 50090-6151 — Dexamethasone, 50090-6152 — Dexamethasone, +556 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels